Mahatme Sandesh (CIK 0001511034)

Latest company ownership

Shares held
11,718
Last filed at
Oct 26, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 13, 2019 Dec 17, 2019 Sarepta Therapeutics, Inc. CFO Sell 2.5 -125,000 -74.76% ✓ $15.7M
Aug 21, 2019 Aug 22, 2019 Sarepta Therapeutics, Inc. CFO Sell 36.3 -100,000 -70.33% ✗ $5.8M
Mar 28, 2019 Mar 29, 2019 Sarepta Therapeutics, Inc. CFO Sell 97.5 +3,696 12.86% ✗ $350.5K
Mar 19, 2019 Mar 20, 2019 Sarepta Therapeutics, Inc. CFO Sell 20.0 -2,625 -8.37% ✗ $332K
Feb 7, 2019 Feb 8, 2019 Sarepta Therapeutics, Inc. CFO Sell 3.8 -65,000 -75.88% ✓ $9.4M
Jan 30, 2019 Feb 1, 2019 Sarepta Therapeutics, Inc. CFO Sell 3.8 -65,000 -68.92% ✓ $8.5M
Oct 24, 2018 Oct 26, 2018 Sarepta Therapeutics, Inc. CFO Sell 2.5 -107,524 -83.88% ✓ $13.7M
Aug 8, 2018 Aug 8, 2018 Sarepta Therapeutics, Inc. CFO Sell 37.5 -8,501 -17.98% ✗ $1M
May 22, 2018 May 24, 2018 Sarepta Therapeutics, Inc. CFO Sell 42.5 -2,024 -4.10% ✗ $180.6K
Mar 15, 2018 Mar 16, 2018 Sarepta Therapeutics, Inc. CFO Sell 22.5 -734 -1.69% ✗ $59.6K
Aug 3, 2017 Aug 7, 2017 Sarepta Therapeutics, Inc. CFO Sell 42.5 -6,264 -13.28% ✗ $237.3K
Jul 20, 2017 Jul 21, 2017 Sarepta Therapeutics, Inc. CFO Sell 5.0 -50,000 -33.99% ✓ $2.1M
Mar 19, 2017 Mar 21, 2017 Sarepta Therapeutics, Inc. CFO Sell 50.0 -171 -0.53% ✗ $5.2K
Oct 17, 2016 Oct 19, 2016 Sarepta Therapeutics, Inc. CFO Sell 5.0 -30,000 -48.76% ✓ $1.5M
Aug 31, 2016 Sep 2, 2016 Sarepta Therapeutics, Inc. CFO Sell 46.3 -1,013 -12.48% ✗ $26.4K
Aug 20, 2013 Aug 20, 2013 Sarepta Therapeutics, Inc. CFO Buy 95.0 +5,000 100.00% ✗ $155.5K